WOCKHARDT
|
The Current P/E Ratio of WOCKHARDT is -48.84.
Share Price | ₹1,120.8 | Oct 28,2024 |
Market Cap | ₹17,193.1 Cr | |
Earnings-TTM | ₹-352.0 Cr | TTM-Consolidated Results |
Price/Earnings | -48.84x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WOCKHARDT
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹17,193.1 Cr] as on Oct 28,2024
(/) Earnings [ ₹-352.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -48.84x ]
Thus, for WOCKHARDT , the investors are currently willing to pay -48.84 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WOCKHARDT !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WOCKHARDT over the last five years.
Historical PE (Price/Earnings) ratio chart of WOCKHARDT
PE Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.22x.
- WOCKHARDT 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2021 at 6.12x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does WOCKHARDT 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WOCKHARDT | -352.00 | -48.84 | 17,193.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 40.99 | 456,509.0 |
CIPLA LTD | 4,335.02 | 28.01 | 121,422.0 |
DR REDDYS LABORATORIES LTD | 5,549.00 | 19.73 | 109,505.0 |
ZYDUS LIFESCIENCES LTD | 4,181.90 | 24.22 | 101,293.0 |
DIVIS LABORATORIES LTD | 1,674.00 | 92.14 | 154,240.0 |
MANKIND PHARMA LTD | 1,976.25 | 49.23 | 97,300.4 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 62.25 | 112,171.0 |
LUPIN LTD | 2,287.78 | 43.95 | 100,550.0 |
AUROBINDO PHARMA LTD | 3,533.22 | 23.57 | 83,278.2 |
ABBOTT INDIA LTD | 1,238.99 | 48.72 | 60,360.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WOCKHARDT 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -48.84x |
Max industry PE | 92.14x |
Median industry PE | 40.99x |
Average industry PE | 34.91x |
You may also like the below Video Courses